Ivan Bergstein
2011
In 2011, Ivan Bergstein earned a total compensation of $525.9K as President and Chief Executive Officer at Stemline Therapeutics.
Compensation breakdown
| Option Awards | $175,870 |
|---|---|
| Salary | $350,000 |
| Total | $525,870 |
Bergstein received $350K in salary, accounting for 67% of the total pay in 2011.
Bergstein also received $175.9K in option awards.
Rankings
In 2011, Ivan Bergstein's compensation ranked 7,871st out of 10,747 executives tracked by ExecPay. In other words, Bergstein earned more than 26.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,871 out of 10,747 | 27th |
Division Manufacturing | 2,877 out of 3,960 | 27th |
Major group Chemicals And Allied Products | 713 out of 1,033 | 31st |
Industry group Drugs | 506 out of 781 | 35th |
Industry Pharmaceutical Preparations | 391 out of 571 | 32nd |
Source: SEC filing on April 30, 2014.
Bergstein's colleagues
We found one more compensation record of an executive who worked with Ivan Bergstein at Stemline Therapeutics in 2011.
2011
Eric Rowinsky
Stemline Therapeutics